Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lyell Immunopharma Inc (NQ: LYEL ) 1.315 -0.725 (-35.54%) Streaming Delayed Price Updated: 12:42 PM EDT, Jun 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,247,052 Open 1.690 Bid (Size) 1.310 (13) Ask (Size) 1.320 (11) Prev. Close 2.040 Today's Range 1.265 - 1.700 52wk Range 1.320 - 3.410 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology Today 7:00 EDT From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference June 03, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Performance YTD -37.68% -37.68% 1 Month -52.18% -52.18% 3 Month -32.22% -32.22% 6 Month -38.26% -38.26% 1 Year -58.91% -58.91% More News Read More Why Lyell Immunopharma Shares Are Rising Today November 10, 2023 Via Benzinga Lyell Immunopharma to Participate in BofA Securities Health Care Conference May 07, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024 May 06, 2024 Via InvestorPlace Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024 May 06, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session April 16, 2024 Via Benzinga Topics Stocks Exposures US Equities Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 12, 2024 Via Benzinga Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday April 12, 2024 Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 12, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session April 11, 2024 Via Benzinga BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday April 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Via Benzinga Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting March 05, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday March 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 February 28, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Announces Participation in March Investor Conferences February 26, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Lyell Immunopharma, Inc Via GlobeNewswire Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Via Benzinga Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 10, 2023 Via Benzinga Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 10, 2023 Via Benzinga Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma November 09, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023 November 07, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing October 31, 2023 From Lyell Immunopharma, Inc Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
